View in EDS

EE119 Cost Effectiveness of Asciminib for the Post 2 Tyrosine Kinase Inhibitor Treatment of Chronic Phase Chronic Myeloid Leukaemia in Türkiye.

Saved in:

Bibliographic Details
Title:	EE119 Cost Effectiveness of Asciminib for the Post 2 Tyrosine Kinase Inhibitor Treatment of Chronic Phase Chronic Myeloid Leukaemia in Türkiye.
Authors:	Tatar, M¹ (AUTHOR), Kaplan, B² (AUTHOR), Arbay, D³ (AUTHOR), Akdemir, AC³ (AUTHOR)
Source:	Value in Health. 2024 Supplement, Vol. 27 Issue 12, pS77-S77. 1p.
Database:	Academic Search Ultimate

Description
ISSN:	10983015
DOI:	10.1016/j.jval.2024.10.403